Keytruda (pembrolizumab) — Merck's anti-PD-1 monoclonal antibody that has become the world's highest-revenue pharmaceutical product surpassing Humira — represents the most commercially successful oncology drug in history, with the Keytruda Market reflecting pembrolizumab's extraordinary commercial momentum across an unprecedented portfolio of approved indications.
Pembrolizumab's...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Portuguese
Italiano
Portuguese (Brazil)
china